AIG
American International Group Portfolio holdings
AUM
$4.37B
1-Year Return
20.39%
This Quarter Return
+6.37%
1 Year Return
+20.39%
3 Year Return
+105.46%
5 Year Return
+176.37%
10 Year Return
+365.07%
AUM
$29.5M
AUM Growth
+$1.01M
(+3.6%)
Cap. Flow
-$403K
Cap. Flow
% of AUM
-1.37%
Top 10 Holdings %
Top 10 Hldgs %
18.03%
Holding
3,422
New
250
Increased
849
Reduced
1,936
Closed
321
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$264K |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$135K |
| 3 |
iShares Preferred and Income Securities ETF
PFF
|
+$78.7K |
| 4 |
Invesco Senior Loan ETF
BKLN
|
+$57.6K |
| 5 |
Cullinan Oncology
CGEM
|
+$31.5K |
Top Sells
| 1 |
SAL
Salisbury Bancorp, Inc.
SAL
|
+$75.1K |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$61.4K |
| 3 |
Charles River Laboratories
CRL
|
+$27.6K |
| 4 |
Apple
AAPL
|
+$24.8K |
| 5 |
JPMorgan Chase
JPM
|
+$23.4K |
Sector Composition
| 1 | Technology | 20.04% |
| 2 | Healthcare | 13.1% |
| 3 | Consumer Discretionary | 10.59% |
| 4 | Financials | 10.33% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Gorman-Rupp
GRC
$1.13B
| $438 | ﹤0.01% |
12,727
+2,467
| +24% | +$85 |
|
2002
Koppers
KOP
$567M
| $438 | ﹤0.01% |
13,527
-223
| -2% | -$7 |
|
|
ALTA
2003
DELISTED
Altabancorp Common Stock
ALTA
| $438 | ﹤0.01% |
10,105
+845
| +9% | +$37 |
|
2004
PureCycle Technologies
PCT
$2.4B
| $437 | ﹤0.01% |
+18,458
| New | +$437 |
|
2005
The Beauty Health Co
SKIN
$321M
| $437 | ﹤0.01% |
+26,014
| New | +$437 |
|
|
PENG
2006
Penguin Solutions, Inc. Ordinary Shares
PENG
$1.36B
| $437 | ﹤0.01% |
18,332
-1,040
| -5% | -$25 |
|
|
HGEN
2007
DELISTED
HUMANIGEN, INC.
HGEN
| $437 | ﹤0.01% |
+25,132
| New | +$437 |
|
2008
Avantor
AVTR
$8.39B
| $435 | ﹤0.01% |
12,255
+1,148
| +10% | +$41 |
|
2009
Citi Trends
CTRN
$281M
| $435 | ﹤0.01% |
4,995
-540
| -10% | -$47 |
|
2010
Exact Sciences
EXAS
$10.2B
| $435 | ﹤0.01% |
3,498
+367
| +12% | +$46 |
|
2011
Theravance Biopharma
TBPH
$720M
| $434 | ﹤0.01% |
29,873
+2,685
| +10% | +$39 |
|
2012
Syndax Pharmaceuticals
SNDX
$1.34B
| $433 | ﹤0.01% |
25,196
+7,070
| +39% | +$121 |
|
2013
Sportsman's Warehouse
SPWH
$117M
| $433 | ﹤0.01% |
24,394
-540
| -2% | -$10 |
|
2014
Recursion Pharmaceuticals
RXRX
$2.11B
| $432 | ﹤0.01% |
+11,839
| New | +$432 |
|
2015
Shattuck Labs
STTK
$92M
| $432 | ﹤0.01% |
14,905
+7,268
| +95% | +$211 |
|
|
EAR
2016
DELISTED
Eargo, Inc. Common Stock
EAR
| $432 | ﹤0.01% |
541
+304
| +128% | +$243 |
|
2017
Stoneridge
SRI
$228M
| $431 | ﹤0.01% |
14,619
-532
| -4% | -$16 |
|
2018
Mission Produce
AVO
$900M
| $430 | ﹤0.01% |
20,780
+16,470
| +382% | +$341 |
|
2019
Cheniere Energy
LNG
$51.9B
| $430 | ﹤0.01% |
4,952
-238
| -5% | -$21 |
|
|
APPH
2020
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $430 | ﹤0.01% |
+26,869
| New | +$430 |
|
|
INBX
2021
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $430 | ﹤0.01% |
15,642
+10,905
| +230% | +$300 |
|
2022
Century Aluminum
CENX
$2.44B
| $429 | ﹤0.01% |
33,274
-355
| -1% | -$5 |
|
2023
Organogenesis Holdings
ORGO
$625M
| $429 | ﹤0.01% |
25,823
+11,561
| +81% | +$192 |
|
|
CCF
2024
DELISTED
Chase Corporation
CCF
| $428 | ﹤0.01% |
4,167
-133
| -3% | -$14 |
|
2025
Aclaris Therapeutics
ACRS
$211M
| $427 | ﹤0.01% |
+24,328
| New | +$427 |
|